A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general populationJan Lubiński, Timothy G. Lesnick, Maya Ghoussaini et al.|Nature Genetics|2010Cited by 344
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.R. Féty, G. Milano, F. Rolland et al.|PubMed|1998Cited by 114
Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.R. Féty, G. Milano, F. Rolland et al.|PubMed|1995Cited by 21
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk PredictionTetsuro Noguchi, Ute Hamann, Trinidad Caldés et al.|UNC Libraries|2020Cited by 19
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general populationClaude Houdayer, Jonathan J. Morrison, Zachary S. Fredericksen et al.|UNC Libraries|2020Cited by 0